Molecular imaging employs specific biomarkers and imaging agents that target cancer cells. These agents can include radiolabeled compounds, fluorescent dyes, or magnetic particles. When introduced into the body, these agents bind to specific proteins, receptors, or other molecules associated with cancer. Advanced imaging technologies like PET (Positron Emission Tomography), MRI (Magnetic Resonance Imaging), and SPECT (Single Photon Emission Computed Tomography) are then used to detect these agents, creating detailed images of the tumor and its environment.
